AI Biotech/Diagnostics: Neurology

The human brain is a diverse system impacting many aspects of health. Artificial intelligence provides not only a means to better understand the brain, but to better support it as health issues appear. This sector considers general brain function, mental state, sensory, sleep, substance abuse, trauma, speech, microbiome, and specific conditions of the brain.

Top 10 Corporate Owners

Corporation	Patents and Published Applications Count
1. Ibm; Univ Yale	69
2. Inventor	67
3. Boston Scientific	63
4. Philips	35
5. Psomagen	32
6. Halo Neuro	30
7. University Of California	29
8. Medtronic	24
9. Facense	22
10. Spx Development Corporation	20

Invention Categorization and Classification

Classification	Patents and Published Applications
General Activity/Assessment	629
Mental State	381
Sensory	44
Sleep	160
Specific condition	387
Substance Abuse	17
Trauma	68
Speech	37
Microbiome	33

Latest News and Insights

Read All

April 15, 2021

• Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

April 8, 2021

• Capital One is Investing in AI Biotech? What’s in their wallet?

April 1, 2021

• Google AI Reinvents Speech Recognition. Who will follow?

Recent Published Activity in AI Biotech/Diagnostics: Neurology as of April 19, 2024